MedX Health Corp MDX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 30.16% | 65.12% | -26.06% | 47.89% | -16.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.16% | 65.12% | -26.06% | 47.89% | -16.01% |
| Cost of Revenue | 2.34% | 87.78% | 158.10% | 71.98% | 42.22% |
| Gross Profit | 144.09% | 34.94% | -315.30% | 8.00% | -68.41% |
| SG&A Expenses | 22.82% | -23.29% | 265.54% | 97.93% | 22.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.47% | -14.05% | 172.06% | 73.84% | 20.06% |
| Operating Income | -27.20% | 21.37% | -284.94% | -78.66% | -25.16% |
| Income Before Tax | -18.61% | 20.96% | -88.77% | -83.16% | -40.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.61% | 20.96% | -88.77% | -83.16% | -40.47% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.61% | 20.96% | -88.77% | -83.16% | -40.47% |
| EBIT | -27.20% | 21.37% | -284.94% | -78.66% | -25.16% |
| EBITDA | -27.10% | 20.67% | -656.78% | -80.37% | -25.63% |
| EPS Basic | -3.03% | 34.15% | -62.07% | -63.16% | -26.92% |
| Normalized Basic EPS | -10.00% | 34.62% | -44.44% | -58.33% | -25.00% |
| EPS Diluted | -3.03% | 34.15% | -62.07% | -63.16% | -26.92% |
| Normalized Diluted EPS | -10.00% | 34.62% | -44.44% | -58.33% | -25.00% |
| Average Basic Shares Outstanding | 12.77% | 20.42% | 18.83% | 11.78% | 9.87% |
| Average Diluted Shares Outstanding | 12.77% | 20.42% | 18.83% | 11.78% | 9.87% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |